In-depth Profiling of MvfR-Regulated Small Molecules in Pseudomonas aeruginosa after Quorum Sensing Inhibitor

Giuseppe Allegretta1, Christine K Maurer1, Jens Eberhard1

  • 1Department of Drug Design and Optimization, Helmholtz Institute for Pharmaceutical Research SaarlandSaarbrücken, Germany.

Insights

Quorum sensing inhibitors targeting MvfR in Pseudomonas aeruginosa reduce virulence factors and bacterial persistence. MvfR antagonists fully suppressed PQS molecule production, offering a promising therapeutic strategy against infections.

Area of Science:

  • Microbiology
  • Bacterial Pathogenesis
  • Drug Discovery

Background:

  • Pseudomonas aeruginosa is an opportunistic pathogen known for antibiotic resistance.
  • Quorum sensing (QS) is a key virulence regulator in P. aeruginosa.
  • Targeting QS, particularly the MvfR-regulated pathway, is a promising anti-virulence strategy.

Purpose of the Study:

  • To investigate the effects of QS inhibitors (QSIs), specifically MvfR antagonists and PqsBC inhibitors, on the biosynthesis of MvfR-regulated small molecules.
  • To evaluate the impact of these QSIs on bacterial persistence and tolerance.

Main Methods:

  • Utilized synthetic MvfR antagonists and PqsBC inhibitors.
  • Quantified levels of 2'-aminoacetophenone (2-AA), dihydroxyquinoline (DHQ), 4-hydroxy-2-heptylquinoline (HHQ), and 4-hydroxy-2-heptylquinoline-N-oxide (HQNO).
  • Assessed the effect of QSIs on persister cell formation in P. aeruginosa.

Main Results:

  • MvfR antagonists completely inhibited PQS small molecule production, with dose-dependent effects on 2-AA, HQNO, HHQ, and PQS.
  • DHQ levels showed a biphasic response to MvfR antagonists: initial increase followed by suppression.
  • PqsBC inhibitors reduced MvfR ligands but increased 2-AA, DHQ, and HQNO; they showed target selectivity in a pqsC mutant.
  • MvfR antagonism reduced persister cells and 2-AA levels, while PqsBC inhibition did not.

Conclusions:

  • Complete MvfR antagonism effectively suppresses PQS biosynthesis and reduces bacterial persistence.
  • This approach avoids DHQ overproduction and offers a favorable therapeutic outcome against P. aeruginosa infections.
  • Targeting MvfR represents a viable strategy for developing new anti-pseudomonal therapies.